Healthcare technology company Symplr, backed by Clearlake Capital, is in the midst of a single-asset secondaries deal, PE Hub reports. The secondaries process comes after Symplr returned to market earlier this year with Evercore, Goldman Sachs and William Blair exploring transactions including a stake sale, as PE Hub reported in June. Charlesbank made a minority investment in Symplr in a deal that valued the company in the range of $3.3 billion to $3.5 billion. Read more.
Related Posts
2022 Congressional Spending Bill: Health Care Groups Praise Telehealth Options
The ACP and the AHA published statements praising money available for a number of health care agencies and programs.
March 11, 2022
Nathanson Family Foundation Gifts $2.5 Million to Expand Ochsner Hospital for Children Congenital Heart Defect Program in New Orleans
The gift will also support expanding the Fetal Cardiology Clinic at Ochsner Baptist.
May 19, 2022